A Phase 4, Multicenter, Double-Blind, Placebo-Controlled, Parallel Study of Alvimopan for the Management of Postoperative Ileus in Subjects Undergoing Radical Cystectomy.

Trial Profile

A Phase 4, Multicenter, Double-Blind, Placebo-Controlled, Parallel Study of Alvimopan for the Management of Postoperative Ileus in Subjects Undergoing Radical Cystectomy.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Oct 2013

At a glance

  • Drugs Alvimopan (Primary)
  • Indications Intestinal disorders
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 22 Oct 2013 FDA approval for expanded use of alvimopan after surgery that includes bowel resection with primary anastomosis was primarily supported by data from this trial, according to a Cubist media release.
    • 17 Apr 2012 Results have been reported in a Cubist Pharmaceuticals media release.
    • 07 Dec 2011 Planned patients number (280) added as reported by M.D. Anderson Cancer Center.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top